Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to the UK

The forecast for the import of ambergris, civet, and musk for pharmaceutical use to the UK shows a declining trend from 2024 to 2028. In 2023, imports stood at 38.5 thousand kilograms. The annual forecasted values decrease by approximately 2.67% on average per year over the next five years. Year-on-year, the import values see a consistent reduction—around 2.67% between 2024 and 2025, following a similar pattern through to 2028.

Future trends to watch for include:

• Potential regulatory changes regarding the use of animal-derived products in pharmaceuticals, which may further impact import volumes.
• Advancements in synthetic alternatives, which could decrease the demand for natural ingredients such as ambergris, civet, and musk.
• Market and consumer preferences shifting towards sustainable and ethical sourcing practices, potentially influencing overall demand.